BMEA earnings date and last-quarter result: last quarter beat, P/E -1.46. Updated 2026-07-23.
Biomea Fusion (BMEA) Research Hub
Biomea Fusion (BMEA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.6356 USD (+5.92%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.46, market cap 0.08B. This hub links to the full technical, earnings and options research available for BMEA.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.6356 USD (+5.92%) |
| 52-week range | 0.5558 USD – 2.07 USD |
| Trend regime | Range |
| 14-day RSI | 22.7 (Oversold) |
| Trailing P/E | -1.46 |
| Market cap | 0.08B |
| Dividend yield | 0.00% |
Available research for BMEA
Covered Call on BMEA: how it works, illustrative setup around the real 0.6356 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on BMEA: how it works, illustrative setup around the real 0.6356 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on BMEA: how it works, illustrative setup around the real 0.6356 USD price, max profit/loss, breakeven and when to use it. Educational.
BMEA technical analysis: range, last 0.6356 USD, RSI 22.7, 52w range 0.5558 USD–2.07 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is BMEA in?
Biomea Fusion (BMEA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is BMEA in an uptrend or downtrend?
As of 2026-10-26, BMEA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is BMEA's trailing P/E ratio?
BMEA's trailing P/E is -1.46, with a market cap of 0.08B. See the earnings research page for full valuation detail.